john isaacs
john isaacs
Professor of Oncology
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
ES Antonarakis, C Lu, H Wang, B Luber, M Nakazawa, JC Roeser, ...
New England Journal of Medicine 371 (11), 1028-1038, 2014
22212014
Hedgehog signalling in prostate regeneration, neoplasia and metastasis
SS Karhadkar, GS Bova, N Abdallah, S Dhara, D Gardner, A Maitra, ...
Nature 431 (7009), 707-712, 2004
12852004
KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11. 2
JT Dong, PW Lamb, CW Rinker-Schaeffer, J Vukanovic, T Ichikawa, ...
Science 268 (5212), 884-886, 1995
12471995
Activation of programmed cell death in the rat ventral prostate after castration
N Kyprianou, JT Isaacs
Endocrinology 122 (2), 552-562, 1988
8781988
Etiology and disease process of benign prostatic hyperplasia
JT Isaacs, DS Coffey
The Prostate 15 (S2), 33-50, 1989
7971989
A history of prostate cancer treatment
SR Denmeade, JT Isaacs
Nature Reviews Cancer 2 (5), 389-396, 2002
6412002
Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation
N Kyprianou, HF English, JT Isaacs
Cancer research 50 (12), 3748-3753, 1990
6341990
Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene
B Levine, Q Huang, JT Isaacs, JC Reed, DE Griffin, JM Hardwick
Nature 361 (6414), 739-742, 1993
6271993
Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer
SR Denmeade, XS Lin, JT Isaacs
The Prostate 28 (4), 251-265, 1996
5481996
Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation
N Kyprianou, HF English, NE Davidson, JT Isaacs
Cancer research 51 (1), 162-166, 1991
5451991
Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers
JT Isaacs, WB Isaacs, WFJ Feitz, J Scheres
The Prostate 9 (3), 261-281, 1986
5241986
Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death
N Kyprianou, JT Isaacs
Molecular Endocrinology 3 (10), 1515-1522, 1989
5141989
Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma
JT Isaacs, DS Coffey
Cancer research 41 (12 Part 1), 5070-5074, 1981
5141981
Antagonistic effect of androgen on prostatic cell death
JT Isaacs
The Prostate 5 (5), 545-557, 1984
4811984
Implication of cell kinetic changes during the progression of human prostatic cancer.
RR Berges, J Vukanovic, JI Epstein, M CarMichel, L Cisek, DE Johnson, ...
Clinical cancer research 1 (5), 473-480, 1995
4641995
Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss
JT Dong, H Suzuki, SS Pin, GS Bova, JA Schalken, WB Isaacs, JC Barrett, ...
Cancer Research 56 (19), 4387-4390, 1996
3961996
The biology of hormone refractory prostate cancer: Why does it develop?
JT Isaacs
Urologic Clinics of North America 26 (2), 263-273, 1999
3871999
The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin
Y Furuya, P Lundmo, AD Short, DL Gill, JT Isaacs
Cancer research 54 (23), 6167-6175, 1994
3841994
Clinical evidence for and implications of the multistep development of prostate cancer
HB Carter, S Piantadosi, JT Isaacs
The Journal of urology 143 (4), 742-746, 1990
3281990
Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration
HF English, N Kyprianou, JT Isaacs
The Prostate 15 (3), 233-250, 1989
3241989
The system can't perform the operation now. Try again later.
Articles 1–20